Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

References

• Agardh E, Tallroth G, Bauer B, Cavallin-Sjöberg U, Agardh C-D. Retinopathy and nephropathy in insulin-dependent diabetics: an inconsistent relationship? Diabetic Med 1987; 4: 248–50
   Google Scholar
• Feldman J N, Hirsch S R, Beyer W A, L'Esperance F A, Friedman E A. Prevalence of diabetic nephropathy at time of treatment for diabetic retinopathy. Diabetic Renal-Retinal Syndrome, E A Friedman, F A L'Esperance. Grune &Stratton Inc., London 1982; 9–22
   Google Scholar
• Borch-Jonnsen K, Andersen P K, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabeto-logia 1985; 28: 590–6
   PubMedGoogle Scholar
• Wilcken D EL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. J Clin Invest 1976; 57: 1079–82
   PubMed Web of Science ®Google Scholar
• Wilcken D EL, Teddy G S, Gupta V J. Homo-cysteinemia, ischemic heart disease, and the carrier state for homocystinuria. Metabolism 1983; 32: 363–70
   PubMed Web of Science ®Google Scholar
• Brattström L E, Hardebo J E, Hultberg B. Moderate homocysteinemia–a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke 1984; 15: 1012–6
   PubMed Web of Science ®Google Scholar
• Boers G HJ, Smals A GH, Trijbels F JM, Fowler B, Bakkeren J AJM, Schoonderwaldt H C, Kleijer W J, Kloppenborg P WC. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709–15
   PubMed Web of Science ®Google Scholar
• Murphy-Chutorian D R, Wexman M P, Grieco A J, Heininger J A, Glassman E, Gaull G E, Ng S KC, Feit F, Wexman K, Fox A D. Methionine intolerance: a possible risk factor for coronary artery disease. J Am Coll Cardiol 1985; 6: 725–30
   PubMed Web of Science ®Google Scholar
• Kang S, Wong P WK, Cook H Y, Norusis M, Messer J V. Protein-bound homocysteine–a possible risk factor for coronary artery disease. J Clin Invest 1986; 77: 1482–6
   PubMed Web of Science ®Google Scholar
• Israclsson B, Brattström L, Hultberg B. Homocysteinemia and myocardial infarction. Atherosclerosis 1988; 71: 227–33
   PubMedGoogle Scholar
• Malinow M R, Kang S S, Taylor L M, Wong P WK, Coull B, Inahara T, Mukerjee D, Sexton G J, Upson B S. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial disease. Circulation 1989; 79: 1180–8
   PubMed Web of Science ®Google Scholar
• Brattström L, Israelsson B, Norrving B, Bergqvist D, Thöme J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Atherosclerosis 1990; 81: 51–60
   PubMed Web of Science ®Google Scholar
• Wilcken D EL, Gupta V J. Sulphur-containing amino acids in chronic renal failure with particular reference to homocysteine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest 1979; 9: 301–7
   PubMedGoogle Scholar
• Wilcken D EL, Gupta V J, Reddy S G. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci 1991; 58: 427–30
   Google Scholar
• Kang S, Wong P WK, Bidani A, Milanez S. Plasma protein-bound homocysteine in patients requiring chronic haemodialysis. Clin Sci 1983; 65: 335–6
   Google Scholar
• Wilcken D EL, Didman N PB, Tyrrell P A, Robertson M R. Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 1988; 37: 697–701
   PubMed Web of Science ®Google Scholar
• Mudd S H, Skovby F, Levy H L, Pettigrew K D, Wilcken B, Pyeritz R E, Andria G, Boers G HJ, Bromberg I L, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer L. The natural history of homocystinuria due to cystathionine -synthase deficiency. Am J Hum Genet 1985; 37: 1–31
   PubMed Web of Science ®Google Scholar
• Harker L A, Sjichter S J, Scott C R, Ross R. Homocystinemia vascular injury and arterial thrombosis. N Engl J Med 1974; 291: 537–43
   PubMed Web of Science ®Google Scholar
• Harker L A, Ross R, Slichter S J, Scott C R. Homocystine-induced arteriosclerosis, the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976; 58: 731–41
   PubMed Web of Science ®Google Scholar
• Harker L A, Harlan J M, Ross R. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. Circ Res 1983; 53: 731–9
   PubMed Web of Science ®Google Scholar
• Wall R T, Harlan J M, Harker L A, Striker G E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 1980; 18: 113–21
   PubMed Web of Science ®Google Scholar
• Starkebaum G, Harlan J M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370–6
   PubMed Web of Science ®Google Scholar
• Parthasarathy S. Oxidation of low density lipoprotein by thiol compounds leads to its recognition by acetyl LDL receptor. Biochim Biophys Acta 1987; 917: 337–40
   PubMed Web of Science ®Google Scholar
• Heinecke J W, Rosen H, Suzuki L A, Chait A. The role of sulfur-containing amino acids in the superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 1987; 262: 10098–103
   PubMed Web of Science ®Google Scholar
• Foreman J W, Wald H, Blumberg G, Pepc L M, Segal S. Homocystine uptake in isolated rat renal cortical tubules. Metabolism 1982; 31: 613–9
   PubMedGoogle Scholar
• Dudman N PB, Tyrell P A, Wilcken D EL. Homocysteinemia; depressed plasma serine levels. Metabolism 1987; 36: 198–201
   PubMedGoogle Scholar